<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00519805</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000561532</org_study_id>
    <secondary_id>WCTU-FRAGMATIC</secondary_id>
    <secondary_id>Velindre-FRAGMATIC</secondary_id>
    <secondary_id>WCTU-02</secondary_id>
    <secondary_id>EU-20753</secondary_id>
    <secondary_id>PFIZER-WCTU-02</secondary_id>
    <secondary_id>EUDRACT-2005-002438-37</secondary_id>
    <secondary_id>ISRCTN80812769</secondary_id>
    <nct_id>NCT00519805</nct_id>
  </id_info>
  <brief_title>Dalteparin in Preventing Blood Clots in Patients With Lung Cancer</brief_title>
  <official_title>FRAGMATIC - A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin Added to Standard Therapy In Patients With Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Velindre NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Anticoagulants, such as dalteparin, may help prevent blood clots from forming in
      patients with lung cancer. It is not yet known whether dalteparin is effective in preventing
      blood clots in patients with lung cancer.

      PURPOSE: This randomized phase III trial is studying how well dalteparin works in preventing
      blood clots in patients with lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Determine whether the addition of dalteparin results in improved survival.

      Secondary

        -  Determine venous thrombotic event-free survival and metastasis-free survival.

        -  Determine serious adverse events in patients treated with this drug.

        -  Determine the toxicity of this drug in these patients.

        -  Determine the quality of life, breathlessness, anxiety, and depression in patients
           treated with this drug.

        -  Determine the cost effectiveness and cost utility of this drug.

      OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.

        -  Arm I (control): Patients receive anticancer treatment considered appropriate by the
           local medical team.

        -  Arm II: Patients receive anticancer treatment considered appropriate by the local
           medical team. Beginning before the start of the first definitive anticancer treatment,
           patients receive dalteparin subcutaneously daily for up to 24 weeks.

      Quality of life, anxiety, depression, and dyspnea are assessed at baseline, at 12 and 24
      weeks, and then at 9 and 12 months.

      After completion of therapy, patients are followed at 9 months, 1 year, and then every 6
      months for at least 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2007</start_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Venous thrombotic event-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metastasis-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life as measured by EQ-5D</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breathlessness (dyspnea) as measured by the Cancer Dyspnea Scale</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression as measured by the Hospital Anxiety and Depression Scale</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost utility</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">2200</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Thromboembolism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dalteparin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histopathological or cytological diagnosis of primary bronchial carcinoma (small cell
             or non-small cell lung cancer) within the past 6 weeks

          -  No other intrathoracic tumors (e.g., carcinoid tumor, mesothelioma, lymphoma, or lung
             metastases from another primary site)

          -  No clinically apparent brain metastases

        PATIENT CHARACTERISTICS:

          -  ECOG performance status 0-3

          -  Platelet count ≥ 100,000/mm³

          -  Serum creatinine ≤ 150 µmol/L

          -  Willing and able to self-administer dalteparin by daily subcutaneous injection or have
             it administered by a caregiver

          -  Not pregnant or nursing

          -  Fertile female patients must use effective contraception (if sexually active)

          -  No hemorrhagic stroke within the past 3 months

          -  No known bleeding disorder

          -  No hemoptysis of CTC ≥ grade 2 (i.e., symptomatic hemoptysis requiring medical
             intervention)

          -  No central venous catheter requiring the use of thromboprophylaxis

          -  No known hypersensitivity to dalteparin, heparin, or other low molecular weight
             heparins (e.g., history of confirmed or suspected immunologically mediated
             heparin-induced thrombocytopenia; acute gastroduodenal ulcer; or subacute
             endocarditis)

          -  No prior illness likely to interfere with study treatment or comparisons

        PRIOR CONCURRENT THERAPY:

          -  No prior treatment likely to interfere with study treatment or comparisons

          -  More than 12 months since prior and no concurrent therapeutic anticoagulation

          -  No concurrent ketorolac (Toradol®)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fergus Macbeth, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Velindre NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stoke Mandeville Hospital</name>
      <address>
        <city>Aylesbury-Buckinghamshire</city>
        <state>England</state>
        <zip>HP21 8AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Bates, MD</last_name>
      <phone>44-1296-316-555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Furness General Hospital</name>
      <address>
        <city>Barrow in Furness</city>
        <state>England</state>
        <zip>LA14 4LF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fyfe, MD</last_name>
      <phone>44-1524-583-510</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Blackburn Hospital</name>
      <address>
        <city>Blackburn</city>
        <state>England</state>
        <zip>BB2 3HH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wiebke Appel, MD, FRCR, MRCP</last_name>
      <phone>44-1772-522-792</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blackpool Victoria Hospital</name>
      <address>
        <city>Blackpool</city>
        <state>England</state>
        <zip>FY3 8NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew C. Hindley, MD</last_name>
      <phone>44-177-252-2908</phone>
      <email>andrew.hindley@lthtr.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <state>England</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Geldart</last_name>
      <phone>44-1202-726-088</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bristol Haematology and Oncology Centre</name>
      <address>
        <city>Bristol</city>
        <state>England</state>
        <zip>BS2 8ED</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen J. Falk, MD</last_name>
      <phone>44-1935-384-559</phone>
      <email>stephen.falk@ubht.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Burnley General Hospital</name>
      <address>
        <city>Burnley</city>
        <state>England</state>
        <zip>BB10 2PQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wiebke Appel, MD, FRCR, MRCP</last_name>
      <phone>44-772-522-792</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen's Hospital</name>
      <address>
        <city>Burton-upon-Trent</city>
        <state>England</state>
        <zip>DE13 0RB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A.D. Chetiyawardana, MD</last_name>
      <phone>44-283-566-333</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Suffolk Hospital</name>
      <address>
        <city>Bury St. Edmunds</city>
        <state>England</state>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1284-713-195</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Walsgrave Hospital</name>
      <address>
        <city>Coventry</city>
        <state>England</state>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Humber, MD</last_name>
      <phone>44-2476-967-478</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Darlington Memorial</name>
      <address>
        <city>Darlington</city>
        <state>England</state>
        <zip>DL3 6HX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clive Peedell, MD</last_name>
      <phone>44-1643-850-850</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Derbyshire Royal Infirmary</name>
      <address>
        <city>Derby</city>
        <state>England</state>
        <zip>DE1 2QY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muthu Kumar, MD</last_name>
      <phone>44-1332-347-141 ext. 2437</phone>
      <email>muthu.kumar@derbyhospitals.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doncaster Royal Infirmary</name>
      <address>
        <city>Doncaster</city>
        <state>England</state>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-130-236-6666</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dorset County Hospital</name>
      <address>
        <city>Dorchester</city>
        <state>England</state>
        <zip>DT1 2JY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike Bayne, MD</last_name>
      <phone>44-1202-448-648</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Russells Hall Hospital</name>
      <address>
        <city>Dudley</city>
        <state>England</state>
        <zip>DY1 2HQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Grumett, MD</last_name>
      <phone>44-384-456-111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Gateshead</city>
        <state>England</state>
        <zip>NE9 6SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fiona McDonald, MD</last_name>
      <phone>44-191-256-3567</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wycombe General Hospital</name>
      <address>
        <city>High Wycombe</city>
        <state>England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Bates, MD</last_name>
      <phone>44-865-225-601</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kidderminster Hospital</name>
      <address>
        <city>Kidderminster Worcestershire</city>
        <state>England</state>
        <zip>DY11 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1562-513-093</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Lancaster Infirmary</name>
      <address>
        <city>Lancaster</city>
        <state>England</state>
        <zip>LA1 4RP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Fyfe, MD</last_name>
      <phone>44-1524-583-510</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Whipps Cross Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>E11 1NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Wells, MD</last_name>
      <phone>44-20-7601-8044</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Bartholomew's Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Wells, MD</last_name>
      <phone>44-207-601-8044</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen Rollason Cancer Care Centre at North Middlesex Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>N18 1QX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-7472-6115</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Whittington Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>N19 5NF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siow M. Lee, MD, PhD, FRCP</last_name>
      <phone>44-20-7288-5227</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University College Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siow M. Lee, MD, PhD, FRCP</last_name>
      <phone>44-20-7288-5227</phone>
      <email>sm.lee@uclh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCL Cancer Institute</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-7472-6115</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Luton and Dunstable Hospital</name>
      <address>
        <city>Luton</city>
        <state>England</state>
        <zip>LU4 0DZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1582-497-513</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <state>England</state>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clive Peedell, MD</last_name>
      <phone>44-643-850-850</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Milton Keynes General Hospital</name>
      <address>
        <city>Milton Keynes</city>
        <state>England</state>
        <zip>MK6 5LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hany Eldeeb, MD</last_name>
      <phone>44-1604-523-815</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newcastle Upon Tyne Hospitals NHS Trust</name>
      <address>
        <city>Newcastle-Upon-Tyne</city>
        <state>England</state>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-191-256-3555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Paget Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>England</state>
        <zip>NR31 6LA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1603-287-674</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Tyneside Hospital</name>
      <address>
        <city>North Shields</city>
        <state>England</state>
        <zip>NE29 8NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-191-256-3555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Friarage Hospital</name>
      <address>
        <city>North Yorkshire</city>
        <state>England</state>
        <zip>DL6 1JG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clive Peedell, MD</last_name>
      <phone>44-643-850-850</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northampton General Hospital</name>
      <address>
        <city>Northampton</city>
        <state>England</state>
        <zip>NN1 5BD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1604-543-789</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Vernon Cancer Centre at Mount Vernon Hospital</name>
      <address>
        <city>Northwood</city>
        <state>England</state>
        <zip>HA6 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanette Dickson, MD</last_name>
      <phone>44-923-844-551</phone>
      <email>jeanette.dickson@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <state>England</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom W. Roques, MD</last_name>
      <phone>44-603-287-671</phone>
      <email>tom.roques@nnuh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <state>England</state>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-115-969-1169</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>George Eliot Hospital</name>
      <address>
        <city>Nuneaton</city>
        <state>England</state>
        <zip>CV10 7DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Hocking, MD</last_name>
      <phone>44-2476-967-490</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <state>England</state>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Yiannakis, MD</last_name>
      <phone>44-1752-439-103</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dorset Cancer Centre</name>
      <address>
        <city>Poole Dorset</city>
        <state>England</state>
        <zip>BH15 2JB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Laurence, MD</last_name>
      <phone>44-1202-448-262</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rosemere Cancer Centre at Royal Preston Hospital</name>
      <address>
        <city>Preston</city>
        <state>England</state>
        <zip>PR2 9HT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geraldine Skailes, MD</last_name>
      <phone>44-1772-522-913</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Berkshire Cancer Centre at Royal Berkshire Hospital</name>
      <address>
        <city>Reading</city>
        <state>England</state>
        <zip>RG1 5AN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Brown, MD</last_name>
      <phone>44-118-322-8343</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alexandra Healthcare NHS</name>
      <address>
        <city>Redditch, Worcestershire</city>
        <state>England</state>
        <zip>B98 7UB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanna Hamilton, MD</last_name>
      <phone>44-2476-967-477</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scarborough General Hospital</name>
      <address>
        <city>Scarborough</city>
        <state>England</state>
        <zip>YO12 6QL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1482-701-151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Research Centre at Weston Park Hospital</name>
      <address>
        <city>Sheffield</city>
        <state>England</state>
        <zip>S1O 2SJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penella J. Woll, MD, PhD</last_name>
      <phone>44-14-226-5235</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wexham Park Hospital</name>
      <address>
        <city>Slough, Berkshire</city>
        <state>England</state>
        <zip>SL2 4HL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1753-634-191</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Tyneside District Hospital</name>
      <address>
        <city>South Shields</city>
        <state>England</state>
        <zip>NE34 0PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Goudarz Mazdai, MD, PhD</last_name>
      <phone>44-191-202-4010</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Staffordshire General Hospital</name>
      <address>
        <city>Stafford</city>
        <state>England</state>
        <zip>ST16 3SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Brammer, MD</last_name>
      <phone>44-902-695-201</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Staffordshire</name>
      <address>
        <city>Stoke-On-Trent</city>
        <state>England</state>
        <zip>ST4 7LN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1782-554-974</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Marsden - Surrey</name>
      <address>
        <city>Sutton</city>
        <state>England</state>
        <zip>SM2 5PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-8661-3278</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Warwickshire Hospital</name>
      <address>
        <city>Warwick, Warwickshire</city>
        <state>England</state>
        <zip>CV34 5BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Humber, MD</last_name>
      <phone>44-2476-967-478</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weston General Hospital</name>
      <address>
        <city>Weston-super-Mare</city>
        <state>England</state>
        <zip>BS23 4TQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher J. Williams, DM, FRCP</last_name>
      <phone>44-1934-881-136</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <state>England</state>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Ferry, MD</last_name>
      <phone>44-1245-516-598</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yeovil District Hospital</name>
      <address>
        <city>Yeovil</city>
        <state>England</state>
        <zip>BA21 4AT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen J. Falk, MD</last_name>
      <phone>44-932-384-559</phone>
      <email>stephen.falk@swest.uhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ysbyty Gwynedd</name>
      <address>
        <city>Bangor</city>
        <state>Wales</state>
        <zip>LL57 2PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Stuart, MD</last_name>
      <phone>44-1248-384-150</phone>
      <email>nick.stuart@nww-tr.wales.nus.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Velindre Cancer Center at Velindre Hospital</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 2TL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fergus Macbeth, MD</last_name>
      <phone>44-292-031-6232</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Llandough Hospital</name>
      <address>
        <city>Llandough</city>
        <state>Wales</state>
        <zip>CF64 2XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fergus Macbeth, MD</last_name>
      <phone>44-29-2061-5888</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Glamorgan Hospital</name>
      <address>
        <city>Llantrisant</city>
        <state>Wales</state>
        <zip>CF72 8XR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-2920-615-888</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince Charles Hospital</name>
      <address>
        <city>Mid Glamorgan</city>
        <state>Wales</state>
        <zip>CF47 9DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fergus Macbeth, MD</last_name>
      <phone>44-29-2061-5888</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Gwent Hospital</name>
      <address>
        <city>Newport Gwent</city>
        <state>Wales</state>
        <zip>NP9 2UB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1633-623-623</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glan Clwyd Hospital</name>
      <address>
        <city>Rhyl, Denbighshire</city>
        <state>Wales</state>
        <zip>LL 18 5UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Garcia-Alonso, MD</last_name>
      <phone>44-1745-583-910</phone>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Griffiths GO, Burns S, Noble SI, Macbeth FR, Cohen D, Maughan TS. FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer. BMC Cancer. 2009 Oct 6;9:355. doi: 10.1186/1471-2407-9-355.</citation>
    <PMID>19807917</PMID>
  </results_reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2007</study_first_submitted>
  <study_first_submitted_qc>August 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2007</study_first_posted>
  <last_update_submitted>August 5, 2011</last_update_submitted>
  <last_update_submitted_qc>August 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2011</last_update_posted>
  <keyword>thromboembolism</keyword>
  <keyword>extensive stage small cell lung cancer</keyword>
  <keyword>limited stage small cell lung cancer</keyword>
  <keyword>stage IV non-small cell lung cancer</keyword>
  <keyword>stage II non-small cell lung cancer</keyword>
  <keyword>stage IIIA non-small cell lung cancer</keyword>
  <keyword>stage IIIB non-small cell lung cancer</keyword>
  <keyword>stage I non-small cell lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dalteparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

